NSE
Anlon Healthcare LimitedAHCL
Anlon Healthcare Limited is an Indian pharmaceutical company focused on the manufacturing and distribution of healthcare products.
| Key products | Pharmaceuticals, medical devices |
|---|---|
| Geography | India, with regional presence in Southeast Asia |
| Competitors | Cadila Healthcare, Dr. Reddy's Laboratories |
AI-generated overview — verify before relying on it.
Net institutional flow
−₹19.3 Cr
Institutional buyers
5 in / 7 out
High-impact filings
0 · tilt Neutral
Next corporate action
Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
ex 2026-04-24
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹7.2 Cr | 157 | — | — | — | — |
| 2 | QUADFUTURE | +₹0.1 Cr | 148 | — | — | — | — |
| 3 | MOBIKWIK | +₹0.1 Cr | 83 | — | — | — | — |
| 4 | MTNL | +₹0 Cr | 2 | — | — | — | — |
| 5 | GATECH | +₹0 Cr | 8 | — | — | — | — |
| 6 | IRMENERGY | −₹2.2 Cr | 328 | — | — | — | — |
| 7 | AHCLThis | −₹17.9 Cr | 4 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Weaknesses
- • [object Object]
- • [object Object]
Opportunities
- • [object Object]
- • [object Object]
Threats
- • [object Object]
- • [object Object]
AI-generated from our data — verify before relying on it.
- 2026-06-11FilingAnlon Healthcare Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (LODR) ReUpdates
- 2026-06-09BulkSELL · ₹14.4 CrNEOMILE GROWTH FUND-SERIES I
- 2026-06-09FilingAnlon Healthcare Limited has informed the Exchange regarding Media Interaction of Chairman & Managing DirectorManagement
- 2026-06-09FilingAnlon Healthcare Limited has informed the Exchange about TranscriptInvestor Call
- 2026-06-09NetDay net −₹14.4 Cr
- 2026-04-24BulkSELL · ₹3.4 CrNEOMILE GROWTH FUND-SERIES I
- 2026-04-24ActionFace Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per ShareSplit
- 2026-04-24ActionBonus 1:1Bonus
- 2026-04-24NetDay net −₹3.4 Cr
- 2026-01-21BulkSELL · ₹5.1 CrNEOMILE CORPORATE ADVISORY LIMITED
- 2026-01-21BulkBUY · ₹5 CrNEOMILE GROWTH FUND-SERIES I
- 2026-01-21NetDay net −₹0.1 Cr
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2UpdatesNeutral
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 Invitation for TV Interview on NDTV Profit.'.
Source PDF → - 2ManagementNeutral
No significant share-price impact expected from media interaction disclosure.
Source PDF → - 2
4 deals · 2026-01-21 → 2026-06-09
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2026-06-09 | NEOMILE GROWTH FUND-SERIES I | Institution | SELL | ₹14.4 Cr |
| 2026-04-24 | NEOMILE GROWTH FUND-SERIES I | Institution | SELL | ₹3.4 Cr |
| 2026-01-21 | NEOMILE CORPORATE ADVISORY LIMITED | Institution | SELL | ₹5.1 Cr |
| 2026-01-21 | NEOMILE GROWTH FUND-SERIES I | Institution | BUY | ₹5 Cr |
4 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
Financial results
None yet.
Calls & transcripts
News & chatter on AHCL
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.